BRUKER CORP (BRKR)
US1167941087 - Common Stock
We assign a fundamental rating of 6 out of 10 to BRKR. BRKR was compared to 58 industry peers in the Life Sciences Tools & Services industry. While BRKR has a great profitability rating, there are some minor concerns on its financial health. BRKR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
In the past year BRKR had a positive cash flow from operations.
BRKR had positive earnings in each of the past 5 years.
In the past 5 years BRKR always reported a positive cash flow from operatings.
1.2 Ratios
BRKR has a better Return On Assets (10.05%) than 89.66% of its industry peers.
With an excellent Return On Equity value of 31.02%, BRKR belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
The Return On Invested Capital of BRKR (12.00%) is better than 91.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRKR is above the industry average of 9.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.05% | ||
| ROE | 31.02% | ||
| ROIC | 12% |
ROA(3y)8.62%
ROA(5y)7.63%
ROE(3y)27.84%
ROE(5y)24.34%
ROIC(3y)12.21%
ROIC(5y)11.26%
1.3 Margins
With an excellent Profit Margin value of 14.41%, BRKR belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
In the last couple of years the Profit Margin of BRKR has grown nicely.
Looking at the Operating Margin, with a value of 16.42%, BRKR belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
BRKR's Operating Margin has improved in the last couple of years.
BRKR's Gross Margin of 51.17% is in line compared to the rest of the industry. BRKR outperforms 58.62% of its industry peers.
In the last couple of years the Gross Margin of BRKR has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.42% | ||
| PM (TTM) | 14.41% | ||
| GM | 51.17% |
OM growth 3Y6.87%
OM growth 5Y2.33%
PM growth 3Y21.98%
PM growth 5Y8.74%
GM growth 3Y2.66%
GM growth 5Y1.51%
2. Health
2.1 Basic Checks
BRKR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BRKR has less shares outstanding
BRKR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRKR has an improved debt to assets ratio.
2.2 Solvency
BRKR has an Altman-Z score of 4.24. This indicates that BRKR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BRKR (4.24) is better than 68.97% of its industry peers.
The Debt to FCF ratio of BRKR is 5.27, which is a neutral value as it means it would take BRKR, 5.27 years of fcf income to pay off all of its debts.
BRKR has a Debt to FCF ratio of 5.27. This is in the better half of the industry: BRKR outperforms 75.86% of its industry peers.
A Debt/Equity ratio of 0.84 indicates that BRKR is somewhat dependend on debt financing.
BRKR's Debt to Equity ratio of 0.84 is on the low side compared to the rest of the industry. BRKR is outperformed by 75.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | 5.27 | ||
| Altman-Z | 4.24 |
ROIC/WACC1.02
WACC11.81%
2.3 Liquidity
A Current Ratio of 1.80 indicates that BRKR should not have too much problems paying its short term obligations.
With a Current ratio value of 1.80, BRKR is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
BRKR has a Quick Ratio of 1.80. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.99, BRKR is not doing good in the industry: 89.66% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
BRKR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.53%, which is quite good.
Measured over the past years, BRKR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.87% on average per year.
The Revenue has grown by 17.14% in the past year. This is quite good.
The Revenue has been growing by 9.36% on average over the past years. This is quite good.
EPS 1Y (TTM)14.53%
EPS 3Y25.68%
EPS 5Y13.87%
EPS growth Q2Q8.11%
Revenue 1Y (TTM)17.14%
Revenue growth 3Y14.26%
Revenue growth 5Y9.36%
Revenue growth Q2Q20.62%
3.2 Future
The Earnings Per Share is expected to grow by 13.42% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.46% on average over the next years.
EPS Next Y4.49%
EPS Next 2Y14.06%
EPS Next 3Y13.42%
EPS Next 5YN/A
Revenue Next Year11.83%
Revenue Next 2Y9.41%
Revenue Next 3Y8.1%
Revenue Next 5Y7.46%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 26.14 indicates a quite expensive valuation of BRKR.
Based on the Price/Earnings ratio, BRKR is valued cheaply inside the industry as 82.76% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.73. BRKR is around the same levels.
Based on the Price/Forward Earnings ratio of 25.01, the valuation of BRKR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 84.48% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.41. BRKR is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.14 | ||
| Fwd PE | 25.01 |
4.2 Price Multiples
86.21% of the companies in the same industry are more expensive than BRKR, based on the Enterprise Value to EBITDA ratio.
72.41% of the companies in the same industry are more expensive than BRKR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.86 | ||
| EV/EBITDA | 18.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRKR does not grow enough to justify the current Price/Earnings ratio.
BRKR has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BRKR's earnings are expected to grow with 13.42% in the coming years.
PEG (NY)5.81
PEG (5Y)1.88
EPS Next 2Y14.06%
EPS Next 3Y13.42%
5. Dividend
5.1 Amount
With a yearly dividend of 0.29%, BRKR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.64, BRKR pays a better dividend. On top of this BRKR pays more dividend than 91.38% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.29% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.62%.
BRKR has been paying a dividend for over 5 years, so it has already some track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.62%
Div Incr Years0
Div Non Decr Years7
5.3 Sustainability
6.88% of the earnings are spent on dividend by BRKR. This is a low number and sustainable payout ratio.
BRKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP6.88%
EPS Next 2Y14.06%
EPS Next 3Y13.42%
BRUKER CORP
NASDAQ:BRKR (5/3/2024, 7:00:01 PM)
After market: 70.045 0 (0%)70.045
-0.05 (-0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.18B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.29% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.14 | ||
| Fwd PE | 25.01 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)5.81
PEG (5Y)1.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.05% | ||
| ROE | 31.02% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 16.42% | ||
| PM (TTM) | 14.41% | ||
| GM | 51.17% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.8 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)14.53%
EPS 3Y25.68%
EPS 5Y
EPS growth Q2Q
EPS Next Y4.49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.14%
Revenue growth 3Y14.26%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y